Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Material Contracts, 2014

AKEBIA THERAPEUTICS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2014-11-10: Form 10-Q; Exhibit 10.2; Description Consulting Agreement dated August 5, 2014 between Akebia Therapeutics, Inc. and Robert Shalwitz, M.D..
  • 2014-11-10: Form 10-Q; Exhibit 10.1; Description Separation Agreement dated August 5, 2014 between Akebia Therapeutics, Inc. and Robert Shalwitz, M.D..
FiledFormExhibitDescription
2014-11-1010-Q10.2Consulting Agreement dated August 5, 2014 between Akebia Therapeutics, Inc. and Robert Shalwitz, M.D.
2014-11-1010-Q10.1Separation Agreement dated August 5, 2014 between Akebia Therapeutics, Inc. and Robert Shalwitz, M.D.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33